Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome.

[1]  G. Huffnagle,et al.  IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). , 1998, Journal of immunology.

[2]  A. Casadevall,et al.  Cryptococcus neoformans differently regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human monocytes , 1998, European journal of immunology.

[3]  K. Buchanan,et al.  What makes Cryptococcus neoformans a pathogen? , 1998, Emerging infectious diseases.

[4]  L. Couderc,et al.  [Pulmonary cryptococcosis during HIV infection. 15 cases]. , 1997, Revue des maladies respiratoires.

[5]  A. Casadevall,et al.  Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen‐presenting cells inhibits the T‐suppressor response and enhances delayed‐type hypersensitivity and survival , 1997, Immunology.

[6]  A. Casadevall,et al.  Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro , 1997, Infection and immunity.

[7]  J. Greenspan.  Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease. , 1997, Oral diseases.

[8]  J. Latgé,et al.  Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.

[9]  A. Casadevall,et al.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. , 1997, Journal of immunology.

[10]  A. Casadevall,et al.  Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? , 1996, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[11]  H. Kornfeld,et al.  Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophages: effects of HIV‐1 infection , 1996, AIDS.

[12]  J. Murphy,et al.  Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. , 1996, The Journal of clinical investigation.

[13]  T. Standiford,et al.  The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. , 1995, Journal of immunology.

[14]  T. Walsh,et al.  Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. , 1995, American journal of respiratory and critical care medicine.

[15]  F. Bistoni,et al.  Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. , 1994, American journal of respiratory cell and molecular biology.

[16]  A. J. Oliver,et al.  Morphotypes of oral isolates of Candida albicans from patients infected with the human immunodeficiency virus , 1993 .

[17]  S. Levitz,et al.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. , 1993, The Journal of clinical investigation.

[18]  G. Deepe,et al.  Immunomodulation in the mycoses. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[19]  W. Powderly.  Therapy for cryptococcal meningitis in patients with AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Graybill,et al.  Fungal infections in AIDS patients. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[21]  N. Clumeck,et al.  Fungal infections in the AIDS patient , 1991 .

[22]  J. Bartlett,et al.  Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. , 1991, Reviews of infectious diseases.

[23]  S. Kamholz,et al.  Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS. , 1990, Chest.

[24]  Goodhart Cb,et al.  Cryptococcal infections in patients with AIDS. , 1990 .

[25]  J. Bartlett,et al.  Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. , 1991, Reviews of infectious diseases.

[26]  C. Good,et al.  Cryptococcal infections in patients with AIDS. , 1990, The New England journal of medicine.

[27]  S. Chuck,et al.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.

[28]  R. Eng,et al.  Cryptococcal infections in patients with acquired immune deficiency syndrome. , 1986, The American journal of medicine.

[29]  M. Koss,et al.  The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. , 1986, Archives of pathology & laboratory medicine.

[30]  E. Gelmann,et al.  Cryptococcosis in the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[31]  G. Hutchins,et al.  Pulmonary cryptococcosis. , 1985, Human pathology.

[32]  A. Forrestel,et al.  CRYPTOCOCCOSIS , 1982, The Lancet.

[33]  W. R. Salyer,et al.  Primary complex of Cryptococcus and pulmonary lymph nodes. , 1974, The Journal of infectious diseases.

[34]  J. Bates,et al.  The spectrum of pulmonary cryptococcosis. , 1968, Annals of internal medicine.

[35]  M. Littman,et al.  Cryptococcosis: current status. , 1968, The American journal of medicine.

[36]  J. Layton,et al.  Massive Pulmonary Cryptococcosis. , 1962 .